GO:0044183 protein folding chaperone: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044183 (protein folding chaperone) is a molecular function defined as binding to a protein or protein-containing complex to assist the protein folding process.
• Chaperones do not appear in the final folded structure; they transiently bind non-native polypeptides and use ATP-driven cycles to prevent aggregation and promote productive folding.
• Major chaperone systems include the Hsp70-Hsp90 cascade, the CCT/TRiC chaperonin, and intramolecular chaperones that fold their own polypeptide segments.
• Chaperone-assisted folding is coupled to translation in bacteria and eukaryotes, with ribosome-associated factors coordinating cotranslational folding.
• Loss of chaperone function is linked to cancer, neurodegeneration, and proteostasis disorders, making these proteins attractive therapeutic and research targets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of chaperone gene function in disease and folding pathways.
Description
Protein folding chaperones are molecular machines that bind non-native polypeptides and assist their transition to the native state without becoming part of the final folded protein. The Gene Ontology term GO:0044183, protein folding chaperone, captures this molecular function: binding to a protein or a protein-containing complex to assist the protein folding process. Chaperones are essential across all domains of life because the information encoded in the amino acid sequence is not always sufficient for efficient folding in the crowded cellular environment, where aggregation and misfolding are constant threats. The chaperone network maintains proteostasis by preventing aggregation, refolding stress-denatured proteins, and routing terminally misfolded species to degradation. Major chaperone families include the Hsp70 and Hsp90 systems, the chaperonin CCT/TRiC, and intramolecular chaperones that guide folding of their own polypeptide chains. Because chaperone dysfunction is implicated in cancer, neurodegeneration, and other proteostasis-related diseases, researchers increasingly rely on CRISPR-based models to test causality and to identify chaperone-dependent pathways.
protein folding chaperone At A Glance
| GO ID | GO:0044183 |
|---|---|
| GO term | protein folding chaperone |
| Ontology | molecular_function |
| Synonym | chaperone activity; protein binding involved in protein folding |
| Definition | Binding to a protein or a protein-containing complex to assist the protein folding process. |
| Major function | Assists protein folding by transient binding to non-native polypeptides, preventing aggregation and promoting native state acquisition. |
| Representative systems | Hsp70-Hsp90 cascade, CCT/TRiC chaperonin, intramolecular chaperones, ribosome-associated chaperones. |
| Disease relevance | Cancer, neurodegeneration, proteostasis disorders, and chaperonopathies. |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, HDX-MS, proteomics, ribosome profiling. |
What Is GO:0044183?
GO:0044183 (protein folding chaperone) is a molecular function ontology term defined as binding to a protein or a protein-containing complex to assist the protein folding process. It is synonymous with chaperone activity and protein binding involved in protein folding. This function is distinct from catalytic activities because the chaperone does not covalently modify its substrate; instead, it transiently interacts with folding intermediates to prevent off-pathway aggregation and to promote productive folding, often in an ATP-dependent manner.
Why Is protein folding chaperone Important in Cell Biology?
Protein folding chaperones are central to cellular proteostasis and organismal health. They ensure that newly synthesized polypeptides fold correctly, refold after stress, and are degraded when irreparably damaged. Because chaperone networks buffer against misfolding, their dysfunction contributes to diseases ranging from cancer to neurodegeneration, and their activity influences drug resistance and protein aggregation pathologies. Understanding GO:0044183 therefore has direct implications for basic cell biology, disease mechanism, and therapeutic development.
• Maintains proteostasis by preventing protein aggregation and promoting productive folding.
• Enables cotranslational folding of nascent polypeptides on the ribosome.
• Supports folding of essential kinases, steroid hormone receptors, and other client proteins through the Hsp70-Hsp90 cascade.
• Chaperonin CCT/TRiC folds actin, tubulin, and other cytoskeletal proteins essential for cell division and shape.
• Intramolecular chaperones guide folding of their own polypeptide chains, expanding the functional repertoire of folding assistants.
• Chaperone dysfunction is linked to cancer, neurodegeneration, and chaperonopathies.
• Chaperones are targets for chemical inhibitors and activators in cancer and protein-misfolding diseases.
• CRISPR screens can identify chaperone dependencies and synthetic lethal interactions in disease models.
• HDX-MS and structural methods reveal chaperone conformational cycles and client binding.
• Chaperone expression is stress-regulated, linking folding capacity to environmental and metabolic cues.
Molecular Mechanism of protein folding chaperone
Substrate recognition and binding
In simple terms: Chaperones grab onto partly folded proteins to stop them from clumping together.
Chaperones recognize exposed hydrophobic patches on non-native polypeptides, which are normally buried in the folded state. Hsp70 binds short hydrophobic segments with low affinity and fast exchange, while chaperonins like CCT/TRiC encapsulate substrates in a protected chamber. This binding prevents aggregation and keeps folding intermediates soluble.
ATP-driven conformational cycles
In simple terms: Chaperones use energy from ATP to change shape and release their client at the right time.
Many chaperones are ATPases that cycle between substrate-affinity states. Hsp70 uses ATP binding and hydrolysis to drive client capture and release, often with co-chaperones such as Hsp40 and nucleotide exchange factors. Hsp90 undergoes ATP-dependent conformational changes to mature client proteins, particularly kinases and steroid receptors. The CCT/TRiC chaperonin uses ATP to close its lid and provide an isolated folding chamber.
Cotranslational folding coordination
In simple terms: Chaperones can work on proteins while they are still being made by the ribosome.
In bacteria, trigger factor and DnaK/DnaJ coordinate with the ribosome to fold nascent chains as they emerge from the exit tunnel. In eukaryotes, ribosome-associated chaperones such as the Hsp70 system and NAC assist cotranslational folding and prevent premature interactions. This coupling ensures that folding begins before synthesis is complete, reducing aggregation risk.
Intramolecular chaperone mechanism
In simple terms: Some proteins contain a built-in chaperone segment that helps the rest of the protein fold.
Intramolecular chaperones are polypeptide segments within a protein that assist folding of another part of the same molecule. They often function by preventing premature folding or by guiding domain arrangement, and they may be cleaved after folding is complete. This mechanism expands the definition of chaperone activity beyond trans-acting factors.
Chaperone cascades and cooperation
In simple terms: Different chaperones work in teams, passing clients from one to another.
The Hsp70-Hsp90 cascade exemplifies chaperone cooperation: Hsp70 initially binds clients, which are then transferred via Hop to Hsp90 for final maturation. This sequential handoff is essential for folding of kinases, hormone receptors, and other signaling proteins. Coordination between chaperone systems provides a layered defense against misfolding.
Key Genes Involved in GO:0044183 protein folding chaperone
The following genes encode representative chaperones and co-chaperones that carry out or regulate GO:0044183 protein folding chaperone activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HSPA1A | Hsp70 family chaperone; ATP-dependent binding of non-native polypeptides | Stress response, cancer, neurodegeneration models |
| HSPA8 | Constitutive Hsp70; cotranslational folding and chaperone-mediated autophagy | Proteostasis, autophagy, viral infection |
| HSP90AA1 | Hsp90 alpha; maturation of kinases and steroid receptors | Cancer, drug resistance, client protein folding |
| HSP90AB1 | Hsp90 beta; ATP-dependent chaperone cycle | Cancer, proteostasis, chaperone inhibitor studies |
| DNAJB1 | Hsp40 co-chaperone; stimulates Hsp70 ATPase and client delivery | Protein aggregation, cancer, chaperone cooperation |
| HSPH1 | Hsp105/Hsp110; nucleotide exchange and disaggregation | Neurodegeneration, protein aggregate clearance |
| CCT1 (TCP1) | Chaperonin subunit; folds actin and tubulin | Cytoskeleton, cell cycle, cancer |
| CCT2 | Chaperonin subunit; substrate encapsulation | Protein folding chamber, cytoskeletal folding |
| CCT3 | Chaperonin subunit; allosteric regulation | Chaperonin assembly and function |
| CCT4 | Chaperonin subunit; ATP hydrolysis coordination | Folding of essential cytoskeletal proteins |
| CCT5 | Chaperonin subunit; substrate binding | Neuropathy, cytoskeletal folding |
| CCT6A | Chaperonin subunit; lid formation | Cancer, chaperonin dependency |
| CCT7 | Chaperonin subunit; substrate release | Cell proliferation, proteostasis |
| CCT8 | Chaperonin subunit; complex assembly | Chaperonin structure and function |
| HSPB1 | Small heat shock protein; holds misfolded proteins | Neurodegeneration, aggregation prevention |
| BAG3 | Co-chaperone; links Hsp70 to autophagy | Cardiomyopathy, cancer, proteostasis |
| STIP1 | Hop; bridges Hsp70 and Hsp90 | Chaperone cascade, cancer |
| AHSA1 | Aha1; Hsp90 ATPase activator | Hsp90 regulation, cancer |
How Is protein folding chaperone Regulated?
Chaperone activity is regulated at multiple levels. Transcription of many chaperones is controlled by heat shock factor 1 (HSF1), which responds to proteotoxic stress. The integrated stress response and mTOR signaling influence translational capacity and chaperone demand. Co-chaperones such as DNAJB1, STIP1, and AHSA1 modulate ATPase cycles and client transfer. Post-translational modifications, including phosphorylation and acetylation, further tune chaperone function. In bacteria, ribosome-associated factors coordinate cotranslational folding with translation rate.
protein folding chaperone and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HSP90AA1 | Cancer; client kinase maturation | Knockout and point-mutation cell lines; Hsp90 inhibitor studies |
| HSPA1A | Neurodegeneration; stress protection | Knockout and overexpression models in neuronal cells |
| CCT5 | Sensory neuropathy; cytoskeletal folding | Knock-in of patient mutations; iPSC-derived neurons |
| HSPB1 | Distal hereditary motor neuropathy | Point-mutation knock-in; aggregation assays |
| BAG3 | Cardiomyopathy; autophagy-linked proteostasis | Knockout and tagged knock-in in cardiomyocytes |
Cancer and chaperone addiction
Many cancers depend on elevated chaperone activity to support oncogenic signaling and rapid proliferation. Hsp90 inhibition destabilizes client kinases and receptors, and Hsp70 supports tumor survival under stress. Chaperonin CCT/TRiC is required for folding of cytoskeletal proteins that drive cell division, making it a potential target in cancer.
Neurodegeneration and protein aggregation
Neurodegenerative diseases are characterized by misfolded protein aggregates, and chaperone systems attempt to prevent or clear these species. Hsp70, Hsp90, and small heat shock proteins modulate aggregation of proteins such as tau and alpha-synuclein. Disruption of chaperone-mediated clearance contributes to neuronal dysfunction.
Chaperonopathies and genetic disorders
Mutations in chaperone genes can cause inherited chaperonopathies affecting muscle, nerve, and other tissues. For example, CCT5 mutations are linked to sensory neuropathy, and HspB1 mutations cause distal hereditary motor neuropathy. These disorders highlight the non-redundant roles of specific chaperones in human physiology.
Proteostasis in aging and metabolic disease
Aging is associated with declining chaperone capacity and accumulation of damaged proteins. This decline contributes to metabolic dysfunction and age-related diseases, making chaperone induction a potential therapeutic strategy.
From protein folding chaperone-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the chaperone essential for cell viability? | CRISPR knockout cell line |
| Does a disease-associated mutation alter chaperone function? | Point-mutation knock-in |
| Where does the chaperone localize and interact? | Tagged knock-in (e.g., GFP/HA) |
| Does overexpression rescue a folding defect? | Overexpression cell model |
| Which pathways depend on the chaperone? | CRISPR library screening |
| What are the global folding consequences? | Proteomics and ribosome profiling |
How to Study the protein folding chaperone Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HDX-MS | Conformational dynamics and client binding | Chaperone cycle analysis |
| Cryo-EM | 3D structure of chaperone-substrate complexes | Chaperonin and Hsp90 structures |
| Ribo-seq | Translation and cotranslational folding | Nascent chain chaperone coordination |
| Proteomics | Protein abundance and interactions | Client identification and stress response |
| CRISPR knockout screen | Gene essentiality and dependencies | Chaperone pathway discovery |
| Fluorescence microscopy | Localization and aggregation | Chaperone recruitment to misfolded proteins |
| ATPase assays | Chaperone enzymatic activity | Co-chaperone regulation |
Structural and biophysical methods
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) reveals conformational changes and client binding sites in chaperones. Cryo-EM and X-ray crystallography provide structural snapshots of chaperonin and Hsp70/Hsp90 cycles.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry identifies chaperone clients and co-chaperone networks. Quantitative proteomics assesses global folding stress and chaperone expression changes.
Ribosome profiling and translation studies
Ribo-seq measures translation efficiency and cotranslational folding events, revealing how chaperones coordinate with the ribosome. This method is particularly useful for studying nascent chain folding in bacteria and eukaryotes.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens identify chaperone dependencies and synthetic lethal interactions. Focused libraries targeting chaperone genes enable pathway-level dissection of folding networks.
How CRISPR Can Be Used to Study GO:0044183 protein folding chaperone
Knockout
CRISPR knockout of chaperone genes (e.g., HSPA1A, HSP90AA1, CCT subunits) reveals essentiality and identifies client proteins that depend on the chaperone for folding. Knockout models are used to test synthetic lethality with other stresses.
Point Mutation
Point-mutation knock-in of disease-associated chaperone variants (e.g., CCT5, HSPB1) allows functional analysis of folding defects and aggregation propensity in isogenic backgrounds.
Knock-in
Tagged knock-in of chaperone genes with fluorescent or affinity tags enables live-cell imaging and interactome studies without overexpression artifacts.
Overexpression
Overexpression of chaperones such as Hsp70 or Hsp90 can rescue folding defects and protect against stress, providing gain-of-function models for therapeutic testing.
How EDITGENE Supports protein folding chaperone Research
Researchers studying protein folding chaperone-related genes often need to determine whether a candidate gene is causally involved in folding, stress resistance, or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services to enable precise, reproducible experiments on GO:0044183 and its associated pathways.
Contact EDITGENE today to design your custom CRISPR model for protein folding chaperone research.
Frequently Asked Questions About protein folding chaperone
What is GO:0044183 protein folding chaperone?
GO:0044183 is a Gene Ontology molecular function term defined as binding to a protein or a protein-containing complex to assist the protein folding process.
What genes are involved in protein folding chaperone activity?
Key genes include HSPA1A, HSPA8, HSP90AA1, HSP90AB1, DNAJB1, and the CCT/TRiC subunits (TCP1, CCT2-CCT8).
How do chaperones help proteins fold?
Chaperones bind exposed hydrophobic regions of non-native polypeptides and use ATP-driven cycles to prevent aggregation and promote native folding.
What is the difference between Hsp70 and Hsp90?
Hsp70 binds early folding intermediates, while Hsp90 matures later-stage clients such as kinases and steroid receptors in a cascade.
What is the CCT/TRiC chaperonin?
CCT/TRiC is a barrel-shaped chaperonin that encapsulates substrates like actin and tubulin in an ATP-dependent folding chamber.
How are chaperones linked to disease?
Chaperone dysfunction contributes to cancer, neurodegeneration, and chaperonopathies by impairing proteostasis and client folding.
What methods study chaperone function?
HDX-MS, cryo-EM, Ribo-seq, proteomics, and CRISPR screens are commonly used to study chaperone mechanisms and dependencies.
Can CRISPR knockout be used to study chaperones?
Yes, CRISPR knockout of chaperone genes reveals essentiality, client dependencies, and stress sensitivity.
What are intramolecular chaperones?
Intramolecular chaperones are segments within a protein that assist folding of another part of the same polypeptide.
How does cotranslational folding involve chaperones?
Ribosome-associated chaperones such as trigger factor and Hsp70 systems fold nascent chains as they emerge from the ribosome.
Conclusion
GO:0044183 protein folding chaperone defines a fundamental molecular function that safeguards proteostasis across all domains of life. Chaperones such as Hsp70, Hsp90, and CCT/TRiC cooperate in ATP-driven cycles to fold client proteins, prevent aggregation, and respond to stress. Their dysfunction is linked to cancer, neurodegeneration, and inherited chaperonopathies, making them important research and therapeutic targets. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with proteomics and screening, provide powerful tools to dissect chaperone biology and identify new interventions.
References
- 1. Kim YE et al.. 2013. Molecular chaperone functions in protein folding and proteostasis.. Annu Rev Biochem 82:323-55 PMID: 23746257
- 2. Hartl FU et al.. 2011. Molecular chaperones in protein folding and proteostasis.. Nature 475(7356):324-32 PMID: 21776078
- 3. Shen PS et al.. 2025. Protein folding by the CCT/TRiC chaperone complex.. Curr Opin Struct Biol 91:102999 PMID: 39914052
- 4. Morán Luengo T et al.. 2019. The Hsp70-Hsp90 Chaperone Cascade in Protein Folding.. Trends Cell Biol 29(2):164-177 PMID: 30502916
- 5. Chen YJ et al.. 2008. The intramolecular chaperone-mediated protein folding.. Curr Opin Struct Biol 18(6):765-70 PMID: 18973809
- 6. Schopf FH et al.. 2017. The HSP90 chaperone machinery.. Nat Rev Mol Cell Biol 18(6):345-360 PMID: 28429788
- 7. Georgescauld F et al.. 2019. Hydrogen deuterium exchange mass spectrometry applied to chaperones and chaperone-assisted protein folding.. Expert Rev Proteomics 16(7):613-625 PMID: 31215268
- 8. Roeselová A et al.. 2024. Mechanism of chaperone coordination during cotranslational protein folding in bacteria.. Mol Cell 84(13):2455-2471.e8 PMID: 38908370
